CS Genetics is developing pathbreaking new technology for genomics, based on foundational scientific insights and sophisticated conceptual innovations in sequencing techniques. Our work will accelerate basic biologic research and enable lifesaving new clinical diagnostics. We have an extremely skilled team, a large global intellectual property estate, and amongst the most inventive, ambitious technology roadmaps in life science.

We’re developing a radically-new, instrument-free platform for single-cell sequencing with disruptive throughput and experimental ease. We’re growing our Cambridge Bioinformatics and Software team to help launch a new era of cellular analysis for research and medicine.